Evidence map›Paper›PMID 34448983›Full record

ReviewBiological trace element research2022

Exploring the Role of Heavy Metals and Their Derivatives on the Pathophysiology of COVID-19.

Ali Bahrami, Mohammad Reza Arabestani, Mohammad Taheri, Abbas Farmany, Fatemeh Norozzadeh, Seyed Mostafa Hosseini, Hesam Nozari, Fatemeh Nouri

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Biological trace element research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Harnessing the Natural Toxic Metabolites in COVID-19.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ali BahramiStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammad Reza ArabestaniDepartment of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohammad TaheriDepartment of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Abbas FarmanyDental Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.
Fatemeh NorozzadehStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Seyed Mostafa HosseiniDepartment of Medical Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hesam NozariStudent Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran.
Fatemeh NouriDepartment of Pharmaceutical Biotechnology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran. Fatemenouri1@gmail.com.ORCID http://orcid.org/0000-0002-5315-8923
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many aspects of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its disease, COVID-19, have been studied to determine its properties, transmission mechanisms, and pathology. These efforts are aimed at identifying potential approaches to control or treat the disease. Early treatment of novel SARS-CoV-2 infection to minimize symptom progression has minimal evidence; however, many researchers and firms are working on vaccines, and only a few vaccines exist. COVID-19 is affected by several heavy metals and their nanoparticles. We investigated the effects of heavy metals and heavy metal nanoparticles on SARS-CoV-2 and their roles in COVID-19 pathogenesis. AgNPs, AuNPs, gold-silver hybrid NPs, copper nanoparticles, zinc oxide, vanadium, gallium, bismuth, titanium, palladium, silver grafted graphene oxide, and some quantum dots were tested to see if they could minimize the severity or duration of symptoms in patients with SARS-CoV-2 infection when compared to standard therapy.

Indexed as

COVID-19Metal NanoparticlesMetals, HeavyVaccinesGoldHumansSARS-CoV-2SilverGoldMetals, HeavySilverVaccinesCOVID-19Heavy metals

Identifiers

PMID34448983
PMCPMC8391869
OpenAlexW3194600918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.